Literature DB >> 35040076

The effects of physical exercise in the palliative care phase for people with advanced cancer: a systematic review with meta-analysis.

Kellie Toohey1,2, Michael Chapman3,4, Anne-Marie Rushby5,6,7, Kat Urban8, Gemma Ingham9, Benjamin Singh10.   

Abstract

PURPOSE: The purpose of this systematic review with meta-analysis was to evaluate the safety, feasibility and effectiveness of exercise in the palliative care phase for people with advanced cancer.
METHODS: Electronic databases were searched for exercise randomised controlled trials involving individuals with incurable cancer that were published prior to April 14, 2021. Meta-analyses were performed to evaluate the effects of exercise on health outcomes. Subgroup effects for exercise mode, supervision, intervention duration and cancer diagnosis were assessed.
RESULTS: Twenty-two trials involving interventions ranging between 2 weeks and 6 months were included. Interventions comprised of aerobic (n = 3), resistance (n = 4), mixed-mode (n = 14) and other exercise (n = 1) modalities. Cancer types consisted of lung (n = 6), breast (n = 3), prostate (n = 2), multiple myeloma (n = 1) and mixed cancer types (n = 10). Meta-analysis of 20 RCTs involving 1840 participants showed no difference in the risk of a grade 2-4 adverse event between exercise and usual care (n = 110 adverse events (exercise: n = 66 events; usual care: n = 44 events), RD =  - 0.01 (91% CI =  - 0.01, 0.02); p = 0.24). Overall median recruitment, retention and adherence rates were 56%, 80% and 69%, respectively. Meta-analysis of health outcomes showed effects in favour of exercise for quality of life, fatigue, aerobic fitness and lower-body strength (SMD range = 0.27-0.48, all p < 0.05).
CONCLUSIONS: Participants who engaged in exercise experienced an increase in quality of life, fitness and strength and a decrease in fatigue. IMPLICATIONS FOR CANCER SURVIVORS: Physical activity programs were found to be safe and feasible for people with advanced cancer in the palliative care phase.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Advanced; Aerobic exercise; Cancer; Exercise oncology; Neoplasm; Palliative; Resistance exercise

Year:  2022        PMID: 35040076     DOI: 10.1007/s11764-021-01153-0

Source DB:  PubMed          Journal:  J Cancer Surviv        ISSN: 1932-2259            Impact factor:   4.442


  52 in total

1.  The development of an Integrated Care Pathway for all patients with advanced life-limiting illness - the Supportive Care Pathway.

Authors:  Jill Main; Claire Whittle; Jonathan Treml; John Woolley; Alistair Main
Journal:  J Nurs Manag       Date:  2006-10       Impact factor: 3.325

Review 2.  Differential effects of exercise on cancer-related fatigue during and following treatment: a meta-analysis.

Authors:  Timothy W Puetz; Matthew P Herring
Journal:  Am J Prev Med       Date:  2012-08       Impact factor: 5.043

3.  Cancer survivors' exercise barriers, facilitators and preferences in the context of fatigue, quality of life and physical activity participation: a questionnaire-survey.

Authors:  J M Blaney; A Lowe-Strong; J Rankin-Watt; A Campbell; J H Gracey
Journal:  Psychooncology       Date:  2011-10-06       Impact factor: 3.894

4.  A longitudinal study of exercise barriers in colorectal cancer survivors participating in a randomized controlled trial.

Authors:  Kerry S Courneya; Christine M Friedenreich; H Arthur Quinney; Anthony L A Fields; Lee W Jones; Jeffrey K H Vallance; Adrian S Fairey
Journal:  Ann Behav Med       Date:  2005-04

Review 5.  How Should End-of-Life Advance Care Planning Discussions Be Implemented According to Patients and Informal Carers? A Qualitative Review of Reviews.

Authors:  Alex Hall; Christine Rowland; Gunn Grande
Journal:  J Pain Symptom Manage       Date:  2019-04-18       Impact factor: 3.612

6.  Understanding barriers to exercise implementation 5-year post-breast cancer diagnosis: a large-scale qualitative study.

Authors:  Kate Hefferon; Helen Murphy; Janice McLeod; Nanette Mutrie; Anna Campbell
Journal:  Health Educ Res       Date:  2013-08-22

7.  Feasibility and impact of a physical exercise program in patients with advanced cancer: a pilot study.

Authors:  Ilse A van den Dungen; Constans A Verhagen; Winette T van der Graaf; Jan-Paul van den Berg; Kris C Vissers; Yvonne Engels
Journal:  J Palliat Med       Date:  2014-07-08       Impact factor: 2.947

Review 8.  Comparison of Pharmaceutical, Psychological, and Exercise Treatments for Cancer-Related Fatigue: A Meta-analysis.

Authors:  Karen M Mustian; Catherine M Alfano; Charles Heckler; Amber S Kleckner; Ian R Kleckner; Corinne R Leach; David Mohr; Oxana G Palesh; Luke J Peppone; Barbara F Piper; John Scarpato; Tenbroeck Smith; Lisa K Sprod; Suzanne M Miller
Journal:  JAMA Oncol       Date:  2017-07-01       Impact factor: 31.777

9.  Strength in numbers: patient experiences of group exercise within hospice palliative care.

Authors:  Lorna Malcolm; Gill Mein; Alison Jones; Helena Talbot-Rice; Matthew Maddocks; Katherine Bristowe
Journal:  BMC Palliat Care       Date:  2016-12-13       Impact factor: 3.234

10.  Fatigue, barriers to physical activity and predictors for motivation to exercise in advanced Cancer patients.

Authors:  J Frikkel; M Götte; M Beckmann; S Kasper; J Hense; M Teufel; M Schuler; M Tewes
Journal:  BMC Palliat Care       Date:  2020-03-31       Impact factor: 3.234

View more
  2 in total

1.  Feasibility and Impact of Adapted Physical Activity (APA) in Cancer Outpatients Beginning Medical Anti-Tumoral Treatment: The UMA-CHAPA Study.

Authors:  Amélie Lemoine; Marine Perrier; Camille Mazza; Anne Quinquenel; Mathilde Brasseur; Alain Delmer; Hervé Vallerand; Maxime Dewolf; Eric Bertin; Coralie Barbe; Damien Botsen; Olivier Bouché
Journal:  Cancers (Basel)       Date:  2022-04-14       Impact factor: 6.575

2.  Exercise as cancer treatment: A clinical oncology framework for exercise oncology research.

Authors:  Kerry S Courneya; Christopher M Booth
Journal:  Front Oncol       Date:  2022-09-02       Impact factor: 5.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.